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Background: Extracellular aspartic proteinase (MCAP) produced by Mucor circinelloides in solid state fermentations
has been shown to possess milk clotting activity and represents a potential replacement for bovine chymosin in
cheese manufacturing. Despite its prospects in the dairy industry, the molecular characteristics of this enzyme
remain unknown. This work focuses on MCAP cloning and optimization of heterologous expression in Pichia
pastoris, and characterization of the enzyme.
Results: The cloning of cDNA sequence encoding MCAP from M. circinelloides was performed using a fragment of
approximately 1 kbp as a probe. The fragment was amplified using non-specific primers designed from the
NDIEYYG and KNNYVVFN consensus motifs from aspartic proteinases of different fungi. Gene specific primers were
designed to amplify a full-length cDNA using SMART™ RACE PCR. MCAP was expressed in P. pastoris under the
control of the constitutive GAP promoter. It was shown that P. pastoris secreted non-glycosylated and glycosylated
MCAPs with molecular weights of 33 and 37 kDa, respectively.
Conclusion: A novel MCAP was expressed in P. pastoris and efficiently secreted into the culture medium. The
expression of the heterologous proteins was significantly increased due to advantages in codon usage as
compared to other expression systems. The results suggest that P. pastoris could be exploited as a safe production
platform for the milk clotting enzyme.
Keywords: Aspartic proteinase, Mucor circinelloides, Pichia pastoris, SMART™ RACE PCR (Rapid Amplification of cDNA
Ends), Alpha factor secretion signal, Milk clotting units (MCU)Background
Rennet, a milk coagulant from the abomasum of milk-
fed calves and lambs, is the industrial gold standard in
cheese manufacturing [1]. Chymosin is the major milk-
clotting component of natural rennet preparations ob-
tained from young animals as its activity amounts to
90% of the total observed potency [2]. However, due to
increased demand in cheese products, animal-derived
milk coagulants are not sufficient to cover the produc-
tion. Therefore, the demand has prompted increased re-
search efforts in the manufacture of recombinant and
microbial rennin [3]. Nevertheless, the rennin of micro-
bial origin might be contaminated by other enzymes* Correspondence: m.fernandez-lahore@jacobs-university.de
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distribution, and reproduction in any mediumwhich might affect cheese ripening by causing bitterness
during storage [4].
Until now, several aspartic proteinases (APs) such as
pepsin, rennin, renin, and cathepsin D have been exten-
sively studied. Microbial APs such as rhizopuspepsin and
penicillopepsin have been reported to be either intracellu-
lar or extracellular enzymes with most of them having
been cloned and purified. For example, acid proteinase
from Metschnikowia reukaufii [5] has been cloned and
expressed in Escherichia coli while three clt genes encod-
ing milk-clotting proteinases from Myxococcus xanthus
have been cloned and expressed in E. coli, Saccharomyces
cerevisiae and P. pastoris [3].
It is also known that fungal extracellular thermophilic
proteinases from R. miehei and R. pusillus are still used
as substitutes for calf chymosin in cheese manufacturing
[6]. However, the enzymes are extensively proteolyticCentral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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acteristics. Moreover, the proteinases are resistant to
heat treatment compared to bovine chymosin and thus
can remain active in the curd for longer periods of time
[7]. Additionally, proteinases with low heat stability have
been observed in M. varians [8] and M. circinelloides
[9]. Although studies on the characterization of an acid
proteinase from M. circinelloides were performed, the
molecular characteristics of the enzyme remain unknown.
The mentioned thermo-labile proteinases may provide
technological advantages for industrial utilization. In this
work, the cloning and expression of the aspartic protein-
ase from M. circinelloides was performed.
Methods
Fungal strain, bacterial strains and plasmids
The microorganism used as the source of the gene en-
coding MCAP was M. circinelloides strain DSM 2183
(Deutsche Sammlung von Mikroorganismen und Zellk-
ulturen GmbH, Braunschweig, Germany). E. coli strain
TOP10 [10] was used to amplify the plasmids carrying
the cloned gene. E. coli strains were grown overnight in
Luria-Bertani medium (10 g L-1, tryptone, 5 g L-1 yeast
extract, 5 g L-1 NaCl) at 37°C, 220 rpm. P. pastoris wasTable 1 List of microorganisms and plasmids used in this stud
Strain or plasmid Genotype
Strains
Escherichia coli
TOP10 F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74




DSM 2183 Wild type
Plasmids
pGAPZα-A The pGAPZα-A vector use the GAP promoter to const
proteins in Pichia pastoris. Contains the zeocin resistan
pGAPZα+MCAP pGAPZα-A derivative carrying the whole MCAP gene1.
pGAPZα+MCAP-2 pGAPZα-A derivative carrying the MCAP gene without
pGAPZα+MCAP-3 pGAPZα-A derivative carrying the MCAP gene without
pGAPZα+MCAP-5 pGAPZα-A derivative carrying the MCAP gene without
without an intron2.
pGAPZα+MCAP SP-1 pGAPZα-A derivative carrying from the amino acid seq
of the MCAP gene without an intron1.
pGAPZα+SyMCAP-6 pGAPZα-A derivative carrying the MCAP gene without sig
The original MCAP gene was adapted to the optimal cod
was cloned flush with the Kex2 cleavage site and in frame
frame with the C-terminal polyhistidine tag into the XhoI
1The insert was cloned in frame with the α-factor signal sequence and in frame with th
2The insert was cloned flush with the Kex2 cleavage site and in a frame of the α-fac
the XhoI and NotI site of the pGAPZα-A.grown in YPD medium (10 g L-1 yeast extract, 20 g L-1
peptone, 20 g L- 1 glucose) at 30°C for 3 days with shak-
ing at 250 rpm. When required, the final antibiotics con-
centration for ampicillin was 100 μg mL-1 while for
zeocin it was either 30, 50 or 100 μg mL-1. Plasmid
pGAPZα-A (Invitrogen, Darmstadt, Germany) was used
as the cloning and expression vector. Table 1 shows the
plasmids and strains used in this study.Genomic DNA extraction
For genomic DNA extraction, M. circinelloides DSM
2183 spores (1 × 105 spores) were inoculated into potato
dextrose agar plates (PDA) which were incubated at 24°C
for 3 days. The PDA medium was prepared according to
the supplier’s protocol (Difco, Detroit, MI, USA). About
250 mg of fresh mycelium were collected with tweezers in
a 1.5 mL vial. The mycelium were washed with sterile
water and centrifuged at 5000 g for 2 min. The spores
were lysed in 466 μL TE buffer (10 mM Tris-Cl, pH 8.0,
1 mM EDTA) with 3 μL Proteinase K (20 mg mL-1), 1 μL
RNAse (10 mg mL-1) and 30 μL SDS (100 mg mL-1). The
suspension was mixed gently to avoid shearing the
chromosomal DNA, followed by incubation at 37°C for
1 h. The precipitated DNA was collected by centrifugationy
Reference
recA1 araD139 Δ(ara-leu) 10
Invitrogen
German resource centre for
biological material
itutively express recombinant
ce gene (Sh ble).
Invitrogen
This work
an intron1. This work
an intron2. This work
a signal sequence and This work
uence number 67 to 394 This work
nal sequence and without intron.
on usage of P. pastoris. The insert
of the α- factor signal sequence and in
and NotI site of the pGAPZα-A.
This work
e C-terminal polyhistidine tag into the EcoRI and NotI sites of the pGAPZα-A.
tor signal sequence and in a frame with the C-terminal polyhistidine tag into
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extraction and ethanol precipitation as described [11].
DNA manipulation
Restriction enzymes (EcoRI, XhoI, NotI and AvrII), T4
DNA ligase and Taq DNA polymerase were purchased
from New England Biolabs (Frankfurt, Germany). All en-
zymes were used under the conditions specified by the
manufacturer. Plasmids were isolated using a QIAprep
Spin Miniprep Kit (QIAGEN, Hilden, Germany), and the
PCR products were purified with the QIAquick PCR
Purification Kit (QIAGEN, Hilden, Germany). PCR reac-
tions were performed in a (total volume of 50 μL) Master-
cycler ep gradient S (Eppendorf, Hamburg, Germany). The
recovered PCR fragments and plasmids were sequenced
by Eurofins MWG Operon (Ebersberg, Germany). Plas-
mids were transformed into E. coli and P. pastoris using a
Multiporator (Eppendorf, Hamburg, Germany), according
to the supplier’s protocol.
Total RNA isolation
To obtain the full-length cDNA of MCAP gene, total
RNA was isolated from solid-state culture of the M. cir-
cinelloides as follows: 250 mL Erlenmeyer flasks contain-
ing 10 g of wheat bran moistened with 200 mM HCl, up
to a water content of 120% on a dry basis, and auto-
claved at 121°C for 20 min, were inoculated with 5×106Table 2 Oligonucleotides used for PCR amplification in this st
Primer name
Primers for DNA fragment PCR to obtain a partial sequence of genomic DNA
12 ND-F
M.cir-2R
Primer for 3′-RACE PCR (Gene-specific primer)
GSP-Mucor-1 F
Primer for 5′-RACE PCR (gene-specific primer)
GSP-Mucor-2R








Primers to identify clones containing recombinant plasmids
pGAP-F
AOX1pGAP-Rev
The underlined sequences (GAATTC; EcoRI, CTCGAG; XhoI and GCGGCCGC; NotI) rep
primers. The lowercase letters indicate the Kex2 cleavage sites. The primers (for Firs
SMART RACE cDNA Amplification Kit (Clontech) are not described in the table.spores of M. circinelloides. Cultured for four days at 24°C,
100 mg of the mycelium were collected with tweezers and
immediately used for total RNA extraction using the
RNeasy Plant Mini Kit (QIAGEN, Hilden, Germany).
The concentration and quality of the total RNA was
determined by using the NanoDrop ND-1000 spectro-
photometer (NanoDrop Technologies, Inc. Wilmington,
Delaware, USA).
First-strand cDNA synthesis, 5′-RACE cDNA and 3′-RACE
cDNA
Two microgram of total RNA were used for the synthe-
sis of the first strand of 5′-RACE-Ready cDNA and 3′-
RACE-Ready cDNA. The synthesized first strand cDNA
was used as a template for the 5′-RACE cDNA and 3′-
RACE cDNA using the gene specific reverse primer
GSP-Mucor-2R and forward primer GSP-Mucor-1 F, re-
spectively (Table 2). In these cases, the conditions for
PCR reactions were as described by Clontech (SMART
RACE cDNA Amplification Kit User Manual). The amp-
lified RACE fragments were separated by agarose gel
electrophoresis and recovered using NucleoTrap Gel Ex-
traction Trial Kit (Takara Europe-Clontech, Saint-Germain-
en-Laye, France). Using this technique, the sequences of
the extreme ends of the MCAP gene (5′and 3′) were ob-
tained. Finally, the full-length cDNA sequence of the aspar-
tic proteinase of M. circinelloides (deposited in GenBankudy
Sequence (5′-3′)














resent the additional restriction sites at the 5′ ends of forward and reverse
t-strand cDNA synthesis, 3′-RACE cDNA and 5′-RACE cDNA) provided in the
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the 5′-RACE-Ready cDNA while the genomic MCAP of
the aspartic proteinase (deposited in GenBank under ac-
cession number JQ906106) was amplified from genomic
DNA of M. circinelloides using the forward primers
APMC-Met-F and the reverse primer APMC-stop-R
(Table 2).
The PCR reactions contained the following components
each listed at their final concentrations: 1 × Advantage 2
PCR Buffer, 200 pmol μL-1 dNTPs, 2 pmol μL-1 of each
primer (forward and reverse), 2.5 μL of 5′ first-strand
cDNA (unknown concentration), 1 × Advantage 2 Poly-
merase Mix (Clontech, Palo Alto, CA, USA). PCR was
carried out at an annealing temperature of 61°C.
Amplification of the cDNA encoding MCAP
To clone the full-length cDNA encoding MCAP in M.
circinelloides, a partial sequence of genomic DNA of the
acidic proteinase gene was first obtained. Non-specific
primers (12 ND-F and M.cir-2R) (Table 2) were designed
using the conserved motifs of aspartic proteinases from
different species of filamentous fungi (Figure 1). In this
case, the amino acid sequence of the Mucor bacilliformis
proteinase [12] and those of Rhizopus microspores var.
rhizopodiformis (accession number CAA72511), Rhizopus
niveus (accession number Q03700), Rhizopus microspores
var. chinensis (accession number AAB59306), Rhizopus
microsporus var. chinensis (accession number AAA33881),
Rhizopus microsporus var. chinensis (accession number
AAA33879) and Syncephalastrum racemosum (acces-
sion number AAC69517) were downloaded from the
GenBank and aligned with BLAST.Figure 1 Multiple alignment of the consensus motifs sequences NDIE
Consensus motifs sequences are marked in black arrows. Asterisks indicate
sequence is based on the protein.After PCR, a 956 bp fragment was obtained. PCR
amplification was carried out at an annealing tem-
perature of 52°C using 1.25 U Taq DNA polymerase and
200 ng of genomic DNA. The deduced amino acid se-
quence of the product was aligned with the amino acid
sequence of aspartic proteinase from M. bacilliformis
[12], R. niveus (accession number X56992) and R. micro-
sporus var. chinensis (accession number M63451) using
BLAST algorithm. Since the fragment sequence showed
high similarity to the selected proteinases, gene-specific
primers were designed to perform 5′-RACE and 3′-
RACE as well as for the amplification of a full-length
cDNA of the aspartic proteinase gene from the first
strand 5′-RACE-Ready cDNA of M. circinelloides by
SMART™ RACE PCR Kit (Takara Europe-Clontech,
Saint-Germain-en-Laye, France).
Recombinant plasmids construction and codon usage
adaptation
A set of expression plasmids were constructed by cloning
a partial MCAP, whole MCAP, or SyMCAP gene in frame
with the alpha-factor (α-MF) secretion signal and the C-
terminal polyhistidine tag (6x His tag) into the multiple
cloning site of pGAPZα-A, indicating that all MCAP
products were cloned downstream of the glyceraldehyde-
3-phosphate dehydrogenase (GAP) promoter [13]. The
whole MCAP coding sequence (with intron sequence) was
amplified from M. circinelloides genomic DNA while the
full-length cDNA (without intron) or partial sequence
cDNA (without signal peptide and without intron) encod-
ing MCAP was amplified from the 5′ of the first strand
cDNA. The final concentrations of components for PCRYYG and FLKNNYVVFN of several fungal aspartic proteinases.
conserved amino acids. The number to the right of the amino acid
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buffer, 200 pmol μL-1 dNTPs, 2 pmol μL-1 of each primer,
1 ng μL-1 plasmid DNA, 0.04 units μL-1Taq DNA poly-
merase. The first round of PCR amplification was carried
out at 63°C for 5 cycles, and the second round of amplifi-
cation was at 66°C for 25 cycles. To construct the plasmids
pGAPZα+MCAP, pGAPZα+MCAP-2, pGAPZα+MCAP-
SP1, pGAPZα+MCAP-3 and pGAPZα+MCAP-5, the PCR
reactions were carried out using the following forward
primers: APMC-F, APMC-Met-F, APMC-EcoNaeI-F, XhoI-
N-MCAP-F and MCAP-3 F, respectively. While the reverse
primer APMC-NotI-R was used in all the PCR reactions
(Table 2). The PCR products were purified as previously
described and were digested using restriction enzymes for
which specific sites had been previously added using
primers. The digested PCR products were then ligated
into the appropriate sites of the multiple cloning site of
pGAPZα-A using T4 DNA ligase. Additionally, original
MCAP was adapted to the optimal codon usage of P.
pastoris and cloned in frame with DNA sequence for the
N-terminal α- factor signal sequence, under the GAP pro-
moter (performed by MWG Operon, Ebersberg, Germany).
The final plasmid construct was designated as pGAPZα+
SyMCAP-6. The ligated products were transformed into
electrocompetent E. coli cells with further selection in
LB-zeocin plates and expression was performed using
P. pastoris X-33.
Transformation of recombinant plasmids containing
MCAP gene into P. pastoris
To examine the expression of MCAP constructs in P. pas-
toris under the control of GAP promoter, recombinant
plasmids were digested by AvrII restriction enzyme and
transformed into P. pastoris competent cells (Invitrogen,
Darmstadt, Germany). Eighty microlitres of P. pastoris
cells were mixed with 2.5 μg of linearized recombinant
plasmids. The transformation mixture (100 μL) was plated
on YPD agar plates supplemented with zeocin (100 μg mL-1)
and incubated at 30°C for 4 days. In order to confirm that
P. pastoris contained the recombinant plasmid, PCR and
sequence analysis were performed as previously described.
Production of crude extracellular MCAP
For the production of MCAP in P. pastoris, starter cul-
tures of single colonies of transformants were grown in
25 mL YPD media in 100 mL shake flasks for 20 h at 30°C.
The cultures were inoculated in triplicate in 75 mL YPD
in 250 mL shake flasks to a starting OD600 of 0.1. Cultiva-
tion was carried out for 4 days. Considering that glucose
concentrations above 40 g L-1 did not show any increase
in MCAP activity, enzyme expression was performed in
20 and 40 g L-1 glucose and adjusted to an initial pH of
5.0 and 7 with citric acid. In order to analyze the effect of
temperature in the culture medium on MCAP expression,recombinants were grown at 23, 24, 25, 27 and 30°C, at
initial pH of 5.0. The supernatant from cultures was taken
every 24 h and cells were harvested by centrifugation at
4000 g at 4°C. Thereafter, milk clotting enzyme activity
was analyzed in the supernatant broths. The supernatant
culture from wild type P. pastoris was used as a negative
control.
To analyse MCAP production by M. circinelloides,
6 day cultivation was performed in solid-state reactor.
The crude extract was obtained according to the method
of Areces and coworker [7] and assayed daily in dupli-
cate. The obtained protein was considered as a control
reference MCAP.
Protein determination
The amount of protein in the crude extract, supernatant
broth, as well in the chromatographic fractions was de-
termined according to the Bradford procedure [14] and
bovine serum albumin served as a standard (Fischer Sci-
entific, Schwerte, Germany).
Chromatographic analysis of MCAP
All chromatographic experiments were done using an
ÄKTA purifier system (GE Healthcare, Munich, Germany).
After removal of the cells by centrifugation at 4000 g, 4°C,
he MCAP recombinant protein was purified from the
supernatant by cation-exchange chromatography using a
5 mL HiTrap SP FF column attached to the ÄKTA puri-
fier. The protein extract was adjusted to pH 3.1 using
citric acid, and then a range of 37–48 mL of the mixture
was injected to the previously equilibrated column with
50 mM citric acid buffer pH 3.5 and 75 mM NaCl. After
washing with the same buffer and 75 mM NaCl, the elu-
tion was performed with the same buffer and 200 mM
NaCl and step gradient was developed in 5 column vol-
umes with a flow rate of 1 mL min-1. For protein content
and milk clotting assays, 2.5 mL of chromatographic frac-
tions were collected and analyzed.
SDS-PAGE analysis
The crude extracellular supernatant proteins were de-
salted using a PD-10 column (GE Healthcare, Munich,
Germany) equilibrated with 20 mM phosphate buffer at
pH 7.2. These recombinant products were about 10 times
concentrated at room temperature using Vacuum Con-
centrator 5305 (Eppendorf, Hamburg, Germany) and ap-
plied to a 12.5% SDS-PAGE. Purified enzyme and crude
control reference MCAP were loaded directly into the
SDS-PAGE gel and stained with Coomassie Brilliant Blue.
Milk clotting assay
The milk clotting activity was analyzed according to the
method of Arima and coworkers, with some modifica-
tions [15]. Initially, 1 mL of substrate made of 100 g L-1
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water was added to a 10 mL test tube and the contents
were incubated at 35°C for 10 min. Afterwards, 0.1 mL
of enzyme sample was added to the pre-incubated sub-
strate. One milk clotting unit (MCU) was defined as the
enzyme amount which clotted 1 mL of the substrate
within 40 min at 35°C [15]. Based on this definition, the
clotting activity was calculated according to equation of
Rao and coworker [16], (Equation 1).
MCU mL‐1 ¼ 2 400= t:Eð Þ ð1Þ
where 2400 is the conversion of 40 min to s, t; clotting
time (s) and E; the enzyme volume (mL).
Deglycosylation assay
About 35 μg of crude extracellular protein from the re-
combinant X-33/pGAPZα+MCAP-5 cultivated in YPD
medium at initial pH of 5.0 was digested with 2 units of
endoglycosidase H (endo H) (New England Biolabs,
Frankfurt, Germany) at 37°C for 2 h. The crude protein
had previously been desalted using a PD-10 column and
equilibrated with 20 mM phosphate buffer, pH 6.0.
Proteolytic activity assay
Proteolytic activities (PA) of obtained chromatographic
fractions were measured by the method of Fan and co-
workers using N,N-dimethylcasein (DCM) as the sub-
strate [17]. For the assay, 10 mg of DCM was dissolved
in 1 mL of 20 mM phosphate buffer, pH 5.8. Subse-
quently, 45 μL of the solution was thoroughly mixed
with 45 μL of enzyme sample and incubated at 35°C for
30 minutes. The reaction was stopped using 1.35 mL of
10% ice-cold trichloroacetic acid (TCA). The reaction
sample was kept on ice for 30 min and later centrifuged
at 15000 g for 15 min. The absorbance of the mixture
was measured at 280 nm. To make the reference solu-
tion, TCA was added before the enzyme. One unit of
proteolytic activity (U mL-1) was defined as the amount in
microgram of tyrosine released from DCM per minute
at 35°C. The extinction for tyrosine was taken as
0.005 mL μg-1 cm, (Equation 2).
PA

U=mlð Þ ¼ A280 nm=0:005ð Þ  1:44 V
 1=30ð Þ  1000=45Þ ð2Þ
where V is volume in mL.
Results and discussion
Isolation of the partial MCAP gene
The gene encoding MCAP was amplified by PCR from
M. circinelloides strain DSM 2183. A 959 bp fragment
was amplified using primers designed based on hom-
ology against NDIEYYG and KNNYVVFN consensus
motifs from aspartic proteinase of various species offilamentous fungi (Figure 1). The deduced amino acid
sequence of the obtained 959 bp fragment indicated the
presence of catalytic Asp residues found in most known
aspartic proteinases. In aspartic proteinases, the catalytic
Asp residues is found within the motif Asp–Xaa–Gly in
which Xaa can be either Ser or Thr [18].
Cloning and gene comparison of the cDNA encoding the
acidic proteinase
After obtaining the partial DNA sequence of MCAP,
specific primers were designed for the amplification of
3′-RACE and 5′-RACE of aspartic proteinase gene from
the first-strand cDNA of M. circinelloides by SMART™
RACE PCR. The full-length cDNA of the aspartic pro-
teinase from M. circinelloides was amplified from the 5′
first-strand, while the full-length MCAP encoding the
aspartic proteinase was amplified from genomic DNA of
M. circinelloides.
By comparing the nucleotide sequence of aspartic pro-
teinase amplified from the 5′first-strand cDNA with the
sequence amplified from the genomic DNA of M. circinel-
loides, we found that the whole MCAP has an intron of
63 bp long and encodes 394 amino acid residues (Figure 2).
The amino acid sequence of M. circinelloides MCAP was
further aligned with the M. bacilliformis [12] sequence
and with non-redundant protein database using BLASTX
2.2.24. The highest similarity between the MCAP amino
acid sequence and a M. bacilliformis homolog was found
to be 88% identity. The identity with R. oryzae (accession
number ACL68088), R. microsporus (accession number
CAA72511), R. microsporus var. chinensis (accession num-
ber AAB59305), R. niveus (accession number CAA40284),
and S. racemosum (accession number AAC69517) was 66,
65, 64, 63, and 59%, respectively.
Signal peptide sequence and N-glycosylation site
The analysis of the amino acid sequence by a SignalP 3.0
server identified a cleavage signal sequence site between
positions Ala21 and Ala22 in the MCAP protein (http://
www.cbs.dtu.dk/services/SignalP/). The putative signal
peptide corresponding to the first 21 amino acids;
MKFSLVSSCVALVVMTLAVDA, shows features of sig-
nal peptides, such as a highly hydrophobic region. Add-
itionally, by using the NetNGlyc v1.0 server (Center for
Biological Sequence Analysis, Technical University of
Denmark DTU), one potential N-glycosylation site;
Asn–X–Ser/Thr, was found to be at positions Asn331 in
the MCAP (Figure 2).
Protein expression, purification and SDS-PAGE analysis
To analyze the expression of MCAP gene in P. pastoris,
a set of recombinant plasmids carrying either the partial
or the whole MCAP gene, was cloned into the P. pas-
toris expression vector pGAPZα-A. The secreted MCAP
Figure 3 SDS-PAGE analysis of the extracellular extract from
recombinants X-33/pGAPZα +MCAP-2, X-33/pGAPZα+MCAP-3,
X-33/pGAPZα+MCAP-5, X-33/pGAPZα+MCAP-SP1, M.
circinelloides and P. pastoris X-33 (wild-type). 25 μg of the
concentrated protein products were subjected on each lane of
SDS-PAGE. Samples: Lane 1, molecular standards (kDa); lane 2, secreted
expression from recombinant X-33/pGAPZα+MCAP-5; lane 3, P. pastoris
X-33 (negative control); lane 4, X-33/pGAPZα+MCAP-2; lane 5,
X-33/pGAPZα+MCAP-3; lane 6, X-33/pGAPZα+MCAP-SP1; and
lane 7, secreted expression from M. circinelloides. The asterisk indicates
the authentic MCAP. The arrows indicate the expressed forms (A and
B) of MCAP protein.
Figure 2 The Nucleotide and deduced amino acid sequence of MCAP protein. The deduced amino acid sequence is shown under the
nucleotide sequence. The arrow indicates the proposed signal peptide cleavage site and lowercase letters indicate nucleotides in the intron
sequence. The proposed catalytic Asp residues (motifs DTGS and DTGT) are boxed. The potential N-glycosylation site is underlined. Asterisk indicates
the position of the stop codon (TAA).
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showed that the recombinant yeast X-33/pGAPZα+M-
CAP-5 expressed two forms of MCAP when cultivated
in YPD medium at pH 5.0 (Figure 3, lane 2, Figures 4A
and 5) as well as the recombinant yeast X-33/pGAPZα+-
SyMCAP-6 (Figures 4B, and 5, lanes, 6 and 7). The mo-
lecular mass of the largest protein was 37 kDa while that
of the smallest protein was 33 kDa. Both proteins seem
to have 2.5 kDa of the additional amino acids of the C-
terminal polyhistidine tag since the molecular mass was
distinctly higher than 30 kDa of the single MCAP from
M. circinelloides (Figure 3, lane 7). It was confirmed that,
MCAP was expressed in two forms; one glycosylated and
the other non-glycosylated. Incubation of the MCAP with
endo H resulted in the decrease in the apparent molecular
weight (Figure 4A), giving values identical to those of the
authentic MCAP from M. circinelloides.
None of the other recombinants analyzed in this study
was able to produce MCAP. It is possible that P. pastoris
containing plasmid pGAPZα+MCAP (data not shown)
was unable to cleave the MCAP gene intron sequence.
Such a situation has been shown in S. cerevisiae that did
not secrete R. niveus aspartic proteinase as it contained
an intron sequence [19]. In the case of strain containing
pGAPZα+MCAP-2 and pGAPZα+MCAP-3 (Figure 3,
lanes 4, 5, respectively), the start codon of α-MF secre-
tion signal and start codon of MCAP are each very close
to the promoter, which might have caused some inhib-
ition of transcription. The unsuccessful result of X-33/
pGAPZα+MCAP-SP (Figure 3, lanes 6) could have been
due to the deleted part of MCAP proenzyme sequence,
Figure 4 SDS-PAGE electrophoretic pattern comparisons of
recombinant P. pastoris. (A) Enzymatic analysis of the MCAP
protein with endoglycosidase (Endo H). 25 μg of the protein
products were digested with endo H and subjected to SDS-PAGE.
Lane 1, molecular standards; lane 2, secreted expression from X-33/
pGAPZα+MCAP-5 (digested); lane 3, secreted expression from X-33/
pGAPZα+MCAP-5 (undigested); lane 4, endo H. The arrows indicate
the expressed forms of MCAP protein (above N-glycosylated protein,
below the deglycosylated protein, respectively). (B) Analysis of the
purified MCAP protein on HiTrap SP Sepharose Fast Flow. Lane 1,
molecular standards; lane 2, 10 μg of secreted expression from recombinant
X-33/pGAPZα+SyMCAP-6. The arrows indicate the expressed forms of
MCAP protein (above N-glycosylated protein, below the deglycosylated
protein, respectively).
Figure 5 Kinetics and forms of MCAP secreted by recombinant
X-33/pGAPZα+MCAP-5 and X-33/pGAPZα+SyMCAP-6.
Recombinants were cultured for 24, 48, 72 and 96 hours in YPD
medium (initial medium pH: 5.0 and 7.0) at 24°C. Proteins in the
sample corresponding to 37 μL of the original supernatant broth
were loaded on each lane of SDS-PAGE. Samples: Lane 1, molecular
standards (kDa); lanes 2, 3, 4, 5, and 8, secreted expression from
recombinant X-33/pGAPZα+MCAP-5 (lane 2, 24 h; lane 3, 48 h; lane 4,
72 h; lane 5, 96 h; lane 8, 72 h); lanes 6, 7, and 9, secreted expression from
recombinant X-33/pGAPZα+SyMCAP-6 after 72 hours of cultivation.
Lane 7, 4 μg of purified MCAP protein on HiTrap SP Sepharose Fast
Flow. The arrows indicate the expressed forms of MCAP protein when
the initial pH value of the medium was 5.0 and the lines indicate the
expressed forms of MCAP at initial pH of 7.0.
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form.
Effect of glucose concentration, temperature and initial
pH on MCAP production
Glucose concentration
The activity of the MCAP produced by the recombinant
X-33/pGAPZα+MCAP-5 grown in two concentrations
of glucose as the sole carbon source in the YPD medium
at pH 5.0 and 24°C was compared. When glucose was
used at 20 g L-1 the relative activity of MCAP decreased
to 40% compared to a glucose concentration of 40 g L-1.
The time course of MCAP production by X-33/pGAP-
Zα+MCAP-5 (Figures 5 and 6A) showed that after 24,
48, 72 and 96 h of growth the activity of the crude enzyme
was 13 (7 mg L-1), 172 (54 mg L-1), 257 (110 mg L-1) and
181 MCU mL-1 (100 mg L-1), respectively. Therefore, it
was concluded that the maximum enzyme activity of 257
MCU mL-1 of fermentation broth was after approximately
72 h of cultivation when culture cells were in their late ex-
ponential growth phase and decreased after 96 h when the
cells reached the stationary phase. The increase in activity
was due to the quality of enzyme produced (Figures 5 and6A). Furthermore, when the original MCAP gene was
adapted to the optimal codon usage of P. pastoris, the ex-
pression of aspartic proteinase in P. pastoris (X-33/pGAP-
Zα+SyMCAP-6) increased by nearly 40%. The amount of
MCAP produced after 72 h of cultivation was 186 mg L-1
and the maximum enzyme activity was 580 MCU. The
amount of MCAP in the culture supernatant was esti-
mated as the difference between the calculated proteins
produced from the recombinant P. pastoris and wild-type
P. pastoris, as well as by considering the band intensities
on SDS-PAGE.
Effect of temperature
The recombinant P. pastoris with the original MCAP gene
was grown for 72 h at 23, 24, 25, 27 and 30°C and the en-
zyme activity of 178, 260, 248, 224 and 145 MCU mL-1,
was obtained, respectively. Temperature seemed to affect
MCAP expression in P. pastoris and the optimum
temperature for the MCAP production by X-33/pGAP-
Zα+MCAP-5 was found to be 24°C (Figure 6B).
Effect of pH
The effect of pH on the activity of the recombinant en-
zyme produced in the culture medium incubated at 24°C
Hours



























Figure 6 Extracellular production of MCAP from recombinant P. pastoris X- 33/pGAPZα+MCAP-5. A) Time course in YPD medium
containing 4% glucose at 24°C. B) Production of aspartic proteinase after 72 hours in YPD medium containing 4% glucose. The values shown are
the mean activity with standard deviation obtained from three sets of experiments.
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vestigated. When the initial pH of the culture medium
was 7 instead of 5, the relative enzyme activity was re-
duced to 55.6% while the levels of protein expressed de-
creased only by 5%. Additionally, regardless of the
temperature, X-33/pGAPZα+MCAP-5 and X-33/pGAP-
Zα+SyMCAP-6 produced four forms of the recombinant
protein with molecular weights of 44, 40, 37 and 33 kDa
when the initial pH value of the medium was 7 (Figure 5).
After the cultivation period the pH of the cultivation
media decreased from 7 to 6.3 thus confirming previous
observations made for Mucor sp. Rennin. The model for
the processing of prepro-MPR, a zymogen of Mucor sp.
Rennin expressed in S. cerevisiae, where it was demon-
strated that prepro-MPR matured under the acidic pH
[20]. This suggests that the MCAP forms of 44 and
40 kDa were also glycosylated and inactive. However, they
were converted to the mature proteins with a molecular
weight of 37 and 33 kDa at pH 5.0.
Characterization of MCAP
Optimum pH
The MCAP proteins were tested for milk clotting activity
at various pH values. The maximum activity in all proteins










33 & 37 60 3.6 40
*Enzyme having (2.5 kDa) the additional amino acids of the C-terminal
polyhistidine tag.
**Thermal stability of the enzymes at 55°C, for 30 min.drastically and the damage was irreversible. For this result,
the histidine-tagged recombinant protein (MCAP) was
not purified by affinity chromatography on immobilized
metal (IMAC).
Optimum temperature and thermal stability
The MCAP activity was determined as a function of tem-
perature from 35 to 65°C. It was found that the activity
was highest at 60°C regardless of protein type. In some
cases, activity began to decrease at temperatures above
50°C. For this reason, thermostability was tested by in-
cubating the enzyme samples at temperatures ranging
from 55 to 60°C. The non-purified MCAPs retained 75%
of their activity at 55°C and 40–60% of its activity was
retained at 60°C after 60 min incubation at pH 3.6
(Table 3). Also, it was found that the purified MCAP
could not retain much activity compared to the non-
purified protein. Purified MCAPs retained less than 40%
of their enzyme activity at 55°C after 30 min incubation
at pH 3.6 while the commercial preparation of R. miehei
showed 85% of residual activity under the same condi-
tions. Therefore, the purified MCAPs have a remarkable
difference in thermal stability in comparison to the
commercial protease from R. miehei. The enzymes that
are sensitive to heat treatment are considered suitableTable 4 Clotting and proteolytic activities of P. pastoris
and R. miehei aspartic protease





MCAP 137 7.02 ± 0.28 19.5 ± 0.79
R. miehei 311 11.11 ± 0.27 28.0 ± 0.68
Results shown are the means of three sets of experiments.
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tial alternative for industrial utilization.
Proteolytic activity of purified MCAP
The ratio of milk clotting activity to proteolytic activity
(MCA/PA) of MCAP was compared to the value observed
for commercial rennet preparation. The higher the MCA/
PA ratio the more desirable the enzyme is during cheese
making. Table 4 shows the MCAP ratio of about 20, which
is below the calculated ratio for chymosin preparation.
Conclusion
The expression of MCAP under the control of the consti-
tutive GAP promoter was investigated. P. pastoris was
shown to be a good host for the production of MCAP
protein and the novel MCAP was efficiently secreted into
the medium to concentrations exceeding 180 mg L-1.
Similar results were obtained by Yamashita and coworkers
who cloned the M. pusillus Rennin gene in S. cerevisiae
cells [21]. P. pastoris secreted two forms of MCAPs where
one form was glycosylated while the other was non-
glycosylated and similar to the authentic aspartic protein-
ase of the M. circinelloides. The observation was corre-
lated to the presence of an N-glycosylation site Asn-Phe-
Thr at position Asn331 of the amino acid sequence of
MCAP. Previous reports show that aspartic proteinases
expressed in S. cerevisiae [21,22] and Aspergillus nidulans
were secreted as single protein bands and in most cases
glycosylated [23]. However, previous observations have
shown that a mutant strain defective in N–glycosylation
process of M. pusillus excreted three glycoforms of M.
pusillus proteins [24]. P. pastoris strain SMD1168 trans-
formed with pGAPZα+MCAP-5 also excreted two forms
of MCAPs (unpublished data). Interestingly, the MCAP
protein contains the sequon located towards the C-
terminus (Asn331 according to the MCAP of 394 amino
acid residues). Therefore, P. pastoris can possibly excrete
two forms of MCAPs. Results obtained by Shakin-
Eshleman et al., suggest that a particular amino acid at the
X position of an Asn-X-Ser sequon is critical for Core-
Glycosylation Efficiency (CGE) [25]. They found that the
substitution of the amino acid X with Phe, increases the
efficiency of core glycosylation. In fact, MCAP contains
Phe at the X position of the sequon. The result showed
that the density of the band representing glycosylated re-
combinant protein was more intense than the recombin-
ant non-glycosylated protein.
To elucidate the origin of the two types of proteins, muta-
tions could be generated at the Asn-X-Ser sequon of MCAP.
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